{
    "organizations": [],
    "uuid": "7f4d07537c1729f59d3abc8db258da91a4ba3367",
    "author": "Allison Prang",
    "url": "https://www.wsj.com/articles/board-denies-indian-tribes-push-to-end-challenge-of-restasis-patents-1519655691",
    "ord_in_thread": 0,
    "title": "Board Denies Indian Tribe’s Push to End Challenge of Restasis Patents",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "The U.S. Patent Trial and Appeal Board will hear Mylan NV’s challenge of patents on dry-eye treatment Restasis as the company works to bring a generic version of the product to market.\nThe board on Friday denied a motion from the St. Regis Mohawk Tribe to terminate the patent challenge. The Indian tribe, based in upstate New York, bought the patents for Restasis last year from Allergan PLC, which sold the patents to the tribe with the idea that because the tribe is a sovereign government, it wouldn’t be subject to patent-office... ",
    "published": "2018-02-26T20:46:00.000+02:00",
    "crawled": "2018-02-27T04:05:14.025+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "patent",
        "trial",
        "appeal",
        "board",
        "hear",
        "mylan",
        "nv",
        "challenge",
        "patent",
        "treatment",
        "restasis",
        "company",
        "work",
        "bring",
        "generic",
        "version",
        "product",
        "market",
        "board",
        "friday",
        "denied",
        "motion",
        "regis",
        "mohawk",
        "tribe",
        "terminate",
        "patent",
        "challenge",
        "indian",
        "tribe",
        "based",
        "upstate",
        "new",
        "york",
        "bought",
        "patent",
        "restasis",
        "last",
        "year",
        "allergan",
        "plc",
        "sold",
        "patent",
        "tribe",
        "idea",
        "tribe",
        "sovereign",
        "government",
        "subject"
    ]
}